首页> 外文OA文献 >Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C▿

【2h】

Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C▿

机译：第4周血浆利巴韦林谷浓度预测接受HIV-HCV合并治疗的慢性C型肝炎患者中的C型肝炎病毒（HCV）复发

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Morello, Judit; Soriano, Vincent; Barreiro, Pablo; Medrano, José; Madejón, Antonio; González-Pardo, Gema; Jiménez-Nácher, Inmaculada; González-Lahoz, Juan; Rodríguez-Novoa, Sonia;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Plasma ribavirin trough concentrations at week 4 predict hepatitis C virus (HCV) relapse in HIV-HCV-coinfected patients treated for chronic hepatitis C. [J] . Morello J, Soriano V, Barreiro P, Antimicrobial agents and chemotherapy. . 2010,第4期

机译：血浆利巴韦林谷浓度在第4周时预测接受慢性丙型肝炎治疗的HIV-HCV感染患者中丙型肝炎病毒（HCV）复发。
2. Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients. [J] . Nunez M, Marino A, Miralles C, JAIDS: Journal of acquired immune deficiency syndromes . 2007,第4期

机译：在接受HIV / HCV感染的患者中，聚乙二醇干扰素加病毒唑治疗后，基线血清丙型肝炎病毒（HCV）RNA水平和第4周的反应是复发的最佳预测指标。
3. Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01) [J] . Ingiliz Patrick, Christensen Stefan, Kimhofer Torben, Clinical infectious diseases . 2016,第10期

机译：Sofosbuvir和Ledipasvir连续8周用于治疗HCV单感染和HIV-HCV合并感染的个体的慢性丙型肝炎病毒（HCV）感染：德国丙型肝炎队列（GECCO-01）的结果
4. HLA-C gene in Hepatitis C Virus infected Patients in Egypt, to estimate the relation between HLA-C gene and Interferon/Ribavirin as treatment for hepatitis C virus [C] . SHADEN MUAWIA HANAFY, AMAL AHMED ABBAS, SAFY KABEEL ALY MANSOUR International Conference on Cellular and Molecular Biology, Biophysics and Bioengineering . 2015

机译：HLA-C基因在丙型肝炎病毒中感染埃及患者，估计HLA-C基因和干扰素/利巴韦林与丙型肝炎病毒治疗的关系
5. Hepatitis C virus (HCV) replication in vitro and the effect of HCV on human immunodeficiency virus (HIV-1) coreceptor usage and diversity in the coinfected patient. [D] . Franco, Kelly Flory. 2007

机译：丙型肝炎病毒（HCV）的体外复制以及HCV对合并感染患者中人免疫缺陷病毒（HIV-1）共受体使用和多样性的影响。
6. Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C [O] . Judit Morello, Vincent Soriano, Pablo Barreiro, 2010

机译：血浆利巴韦林谷浓度在第4周时预测接受丙型肝炎治疗的HIV-HCV合并感染患者的丙型肝炎病毒（HCV）复发
7. Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis C virus genotype 1: Are nonresponders and relapsers different populations? [O] . Silva, Giovanni Faria [UNESP], Polonio, Rodrigo Jose [UNESP], Pardini, Maria Ines de Moura Campos [UNESP], 2007

机译：使用聚乙二醇化干扰素α-2b和利巴韦林治疗感染丙型肝炎病毒基因型1的慢性肝炎患者：无反应者和复发者是否不同人群？

Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C▿

著录项

相似文献

相关主题

期刊订阅